Waddell & Associates’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$228K Buy
+2,131
New +$140K 0.01% 483
2026
Q1
Sell
-934
Closed -$16.1K 453
2025
Q4
$16.1K Buy
+934
New +$18.1K ﹤0.01% 378

Other funds holding AGL

Waddell & Associates's AGL Position: Q2 2026 in Review

Waddell & Associates opened a new position in Agilon Health (AGL) in Q2 2026: 2,131 shares worth $228K. The stake represents 0.01% of the portfolio and ranks #483 among its holdings. This is a return to the name: Waddell & Associates previously reported a position in AGL as recently as Q4 2025.

Waddell & Associates first reported a position in AGL in Q4 2025 and has held it in 2 quarters since. 14 funds tracked by Wall St. Rank hold AGL as of Q2 2026.

  • Waddell & Associates held 2,131 shares of Agilon Health worth $228K as of Q2 2026.
  • Agilon Health was a new Waddell & Associates position in Q2 2026.
  • Agilon Health made up 0.01% of Waddell & Associates's portfolio in Q2 2026, its #483 holding.
  • Waddell & Associates first reported a position in Agilon Health in Q4 2025 and has held it in 2 quarters since.
  • 14 funds tracked by Wall St. Rank held Agilon Health as of Q2 2026.

Based on Waddell & Associates's 13F filing for Q2 2026, filed 15 Jul 2026.